Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,

Lynne Shinto, Gail Marracci, S. Baldauf-Wagner, A. Strehlow, Vijayshree Yadav, L. Stuber, Dennis Bourdette

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objectives: The primary objective was to evaluate the effect of omega-3 fatty acids (omega-3 FA) on matrix metalloproteinase-9 (MMP-9) production by immune cells in multiple sclerosis (MS). Quality of life, fatty acid levels, and safety were also evaluated. Materials and Methods: Ten participants with relapsing-remitting MS (RRMS) received omega-3 FA supplementation (9.6 g/day fish oil) in an open-label study. Participants were evaluated at four time points, baseline, after 1 month of omega-3 FA supplementation, after 3 months of omega-3 FA supplementation, and after a 3-month wash out. Results: Immune cell secretion of MMP-9 decreased by 58% after 3 months of omega-3 FA supplementation when compared with baseline levels (p

Original languageEnglish (US)
Pages (from-to)131-136
Number of pages6
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume80
Issue number2-3
DOIs
StatePublished - Feb 2009

Fingerprint

Relapsing-Remitting Multiple Sclerosis
Matrix Metalloproteinase 9
Omega-3 Fatty Acids
Fish Oils
Multiple Sclerosis
Labels
Fatty Acids
Quality of Life
Safety

Keywords

  • Matrix metalloproteinase
  • Multiple sclerosis
  • Omega-3 fatty acids

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry

Cite this

@article{25087c39d2494297bab066d99f6326d6,
title = "Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,",
abstract = "Objectives: The primary objective was to evaluate the effect of omega-3 fatty acids (omega-3 FA) on matrix metalloproteinase-9 (MMP-9) production by immune cells in multiple sclerosis (MS). Quality of life, fatty acid levels, and safety were also evaluated. Materials and Methods: Ten participants with relapsing-remitting MS (RRMS) received omega-3 FA supplementation (9.6 g/day fish oil) in an open-label study. Participants were evaluated at four time points, baseline, after 1 month of omega-3 FA supplementation, after 3 months of omega-3 FA supplementation, and after a 3-month wash out. Results: Immune cell secretion of MMP-9 decreased by 58{\%} after 3 months of omega-3 FA supplementation when compared with baseline levels (p",
keywords = "Matrix metalloproteinase, Multiple sclerosis, Omega-3 fatty acids",
author = "Lynne Shinto and Gail Marracci and S. Baldauf-Wagner and A. Strehlow and Vijayshree Yadav and L. Stuber and Dennis Bourdette",
year = "2009",
month = "2",
doi = "10.1016/j.plefa.2008.12.001",
language = "English (US)",
volume = "80",
pages = "131--136",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",
number = "2-3",

}

TY - JOUR

T1 - Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,

AU - Shinto, Lynne

AU - Marracci, Gail

AU - Baldauf-Wagner, S.

AU - Strehlow, A.

AU - Yadav, Vijayshree

AU - Stuber, L.

AU - Bourdette, Dennis

PY - 2009/2

Y1 - 2009/2

N2 - Objectives: The primary objective was to evaluate the effect of omega-3 fatty acids (omega-3 FA) on matrix metalloproteinase-9 (MMP-9) production by immune cells in multiple sclerosis (MS). Quality of life, fatty acid levels, and safety were also evaluated. Materials and Methods: Ten participants with relapsing-remitting MS (RRMS) received omega-3 FA supplementation (9.6 g/day fish oil) in an open-label study. Participants were evaluated at four time points, baseline, after 1 month of omega-3 FA supplementation, after 3 months of omega-3 FA supplementation, and after a 3-month wash out. Results: Immune cell secretion of MMP-9 decreased by 58% after 3 months of omega-3 FA supplementation when compared with baseline levels (p

AB - Objectives: The primary objective was to evaluate the effect of omega-3 fatty acids (omega-3 FA) on matrix metalloproteinase-9 (MMP-9) production by immune cells in multiple sclerosis (MS). Quality of life, fatty acid levels, and safety were also evaluated. Materials and Methods: Ten participants with relapsing-remitting MS (RRMS) received omega-3 FA supplementation (9.6 g/day fish oil) in an open-label study. Participants were evaluated at four time points, baseline, after 1 month of omega-3 FA supplementation, after 3 months of omega-3 FA supplementation, and after a 3-month wash out. Results: Immune cell secretion of MMP-9 decreased by 58% after 3 months of omega-3 FA supplementation when compared with baseline levels (p

KW - Matrix metalloproteinase

KW - Multiple sclerosis

KW - Omega-3 fatty acids

UR - http://www.scopus.com/inward/record.url?scp=61849109389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849109389&partnerID=8YFLogxK

U2 - 10.1016/j.plefa.2008.12.001

DO - 10.1016/j.plefa.2008.12.001

M3 - Article

VL - 80

SP - 131

EP - 136

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 2-3

ER -